Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Review on the Molecular Pathology of Epithelial Thyroid Tumors Publisher



Razavi SA1 ; Modarressi MH2 ; Yaghmaei P1 ; Hedayati M3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biology, School of Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran
  2. 2. Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Journal of Isfahan Medical School Published:2018


Abstract

Epithelial thyroid tumors are all from the thyrocytes, the follicular epithelial cells of the thyroid. If these cells do not replicate the normal mechanisms of growth, cell division, and apoptosis, and enter to the uncontrolled growth phase, thyroid tumors arise. Most of these tumors are benign, but some of them are slow-growing malignancies, and a small number of them are also highly-invasive cancers. Failure of the natural mechanisms, and creation a tumor can be due to genetic and epigenetic changes in proto-oncogenes and tumor suppressor genes. Understanding molecular pathology of epithelial thyroid tumors, and recognizing molecular changes of proto-oncogenes and tumor suppressor genes can explain their different clinical features, providing diagnostic and prognostic information, and discovering of the effective treatments. On the other hand, it can provide further research opportunities in the diagnosis, prognosis, and treatment areas. This review article targeted the molecular pathology of epithelial thyroid tumors. © 2018, Isfahan University of Medical Sciences(IUMS). All rights reserved.
Related Docs
View other Related Docs
1. Meta-Analysis of Promoter Methylation in Eight Tumor-Suppressor Genes and Its Association With the Risk of Thyroid Cancer, PLoS ONE (2017)
2. Pi3k/Akt Pathway and Its Mediators in Thyroid Carcinomas, Molecular Diagnosis and Therapy (2016)
3. Circrnas: A Novel Strategy in Diagnosis and Treatment of Thyroid Cancer, Current Molecular Medicine (2023)
4. Personalized Treatment Options for Thyroid Cancer: Current Perspectives, Pharmacogenomics and Personalized Medicine (2019)
5. A Review of Driver Genetic Alterations in Thyroid Cancers, Iranian Journal of Pathology (2018)
6. Molecular Biomarkers of Anaplastic Thyroid Carcinoma, Current Molecular Medicine (2017)
7. Circulating Levels of Pten and Klln in Papillary Thyroid Carcinoma: Can They Be Considered As Novel Diagnostic Biomarkers?, Endocrine (2017)
8. Promoter Methylation of Four Tumor Suppressor Genes in Human Papillary Thyroid Carcinoma, Iranian Journal of Pathology (2019)
Experts (# of related papers)
View all Related Experts
Seyed Mohammad Tavangar (8)
Bagher Larijani (6)
Other Related Docs
9. New Evidence on Tumor Suppressor Activity of Pten and Klln in Papillary Thyroid Carcinoma, Pathology Research and Practice (2021)
10. Precision Medicine in Endocrinology Practice, Precision Medicine in Clinical Practice (2022)
11. Circulating Ctdna Methylation Quantification of Two Dna Methyl Transferases in Papillary Thyroid Carcinoma, Journal of Cellular Biochemistry (2019)
12. The Epigenetic Modification of Slc5a8 in Papillary Thyroid Carcinoma and Its Effects on Clinic-Pathological Features, Iranian Journal of Public Health (2022)
13. Expression of Mir-127, Mir-154, and Mir-183 in Medullary Thyroid Carcinoma Tumors, Iranian Journal of Public Health (2021)
14. Nol4 Is Downregulated and Hyper-Methylated in Papillary Thyroid Carcinoma Suggesting Its Role As a Tumor Suppressor Gene, International Journal of Endocrinology and Metabolism (2020)
15. Association of Vitamin D Levels and Receptor Gene Polymorphisms With Medullary Thyroid Cancer, Tehran University Medical Journal (2016)
16. The Role of Micrornas in Different Types of Thyroid Carcinoma: A Comprehensive Analysis to Find New Mirna Supplementary Therapies, Journal of Endocrinological Investigation (2018)
17. Hypermethylated Rassf1 and Slc5a8 Promoters Alongside Brafv600e Mutation As Biomarkers for Papillary Thyroid Carcinoma, Journal of Cellular Physiology (2020)
18. Epithelial-To-Mesenchymal Transition in Thyroid Cancer: A Comprehensive Review, Endocrine (2019)
19. Enhanced Beta-Catenin Expression Is Associated With Recurrence of Papillary Thyroid Carcinoma, Endocrine Practice (2018)
20. Targeting the Braf Signaling Pathway in Cd133pos Cancer Stem Cells of Anaplastic Thyroid Carcinoma, Asian Pacific Journal of Cancer Prevention (2019)